Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Natalia Castano"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
PharmacoEconomics - Open. 6:837-846
The aim of this study was to evaluate the cost effectiveness of tofacitinib versus other treatment options currently available in Colombia in naïve to biologics (first-line) and exposed to biologics (second-line) patients with moderate to severe act
Autor:
Alejandra Alarcon, Natalia Castano, Juan Manuel Reyes, Giovanna Matiz, Diego Moran, Ricardo Brugés, Milton Lombana, Ray Manneh, Eduardo Gutierrez
Objective To evaluate progression free survival (PFS) in patients with advanced or metastatic, hormone receptor positive (HR+), HER2-negative (HER2-) breast cancer treated with palbociclib in combination with fulvestrant as second or later lines of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ac753ca1524627ff4ae10a79c4269f5
https://doi.org/10.21203/rs.3.rs-1762559/v1
https://doi.org/10.21203/rs.3.rs-1762559/v1
Autor:
Gabriel Fernando Torres, Brigitte Alejandra Alarcón, Juan Manuel Reyes-Sanchez, Natalia Castaño-Gamboa, Giancarlo Buitrago
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 22, Iss 1, Pp 1-11 (2024)
Abstract Background Breast Cancer (BC) is associated with substantial costs of healthcare; however, real-world data regarding these costs in Colombia is scarce. The contributory regime provides healthcare services to formal workers and their dependen
Externí odkaz:
https://doaj.org/article/13f243c180fe49738f8a9e55d454d743
Autor:
J. Reyes, Matt Wasserman, Johnna Perdrizet, Natalia Castano, Jorge LaRotta, Rodrigo Sini de Almeida, Mark A. Fletcher
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 22:1-3
Gomez and colleagues [1] recently published a budget impact analysis (BIA) evaluating pneumococcal conjugate vaccines (PCVs) use over 5 years (2020 to 2024) in the National Immunization Program (NI...
Autor:
Laurence D. W. Luu, Abhimanu Pandey, Sudarshan Paramsothy, Chinh Ngo, Natalia Castaño-Rodríguez, Cheng Liu, Michael A. Kamm, Thomas J. Borody, Si Ming Man, Nadeem O. Kaakoush
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-13 (2024)
Abstract Host molecular responses to fecal microbiota transplantation (FMT) in ulcerative colitis are not well understood. Here, we profile the human colonic mucosal transcriptome prior to and following FMT or placebo to identify molecules regulated
Externí odkaz:
https://doaj.org/article/8fb4cb1f0049425d9de3a9f287ea6c0f
Autor:
María Alejandra Burbano, H. A. Nati-Castillo, Natalia Castaño-Giraldo, Gildardo López, Romina Placencia-André, Camila Salazar-Santoliva, Melissa Villavicencio-Gomezjurado, Juan S. Izquierdo-Condoy
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
IntroductionNephrobronchial fistula is an exceptionally rare complication of renal infections, including the uncommon xanthogranulomatous pyelonephritis. Existing literature is limited to a few case reports, with antibiotic therapy and nephrectomy be
Externí odkaz:
https://doaj.org/article/a8bf86c81ee04dbc99778dc1c3ff7e4f
Evaluation of Treatment Patterns and Direct Costs Associated with the Management of Neuropathic Pain
Autor:
Andrés Gaviria-Mendoza, Jorge Enrique Machado-Alba, Natalia Castano, Manuel Enrique Machado-Duque
Publikováno v:
Pain Research & Management
Pain Research and Management, Vol 2020 (2020)
Pain Research and Management, Vol 2020 (2020)
Background. Neuropathic pain has a prevalence of 2–17% in the general population. Diagnosis and treatment of neuropathic pain are not fully described in different populations. The aim was to determine the treatment patterns and direct costs of care
Autor:
S. Mora-Martinez, Natalia Castaño-Giraldo, Humberto Alejandro Nati-Castillo, Laura Barahona Machado, Tatiana Mora Arbeláez, G. Gordillo-Gonzalez, Juan S. Izquierdo-Condoy
Publikováno v:
Frontiers in Pediatrics, Vol 12 (2024)
Purine-rich element-binding protein A (PURα) regulates multiple cellular processes. Rare de novo mutations can lead to PURA syndrome, which manifests as a range of multisystem disturbances, including hypotonia, global developmental delay, swallowing
Externí odkaz:
https://doaj.org/article/cb6bf85bc447470da5e60cb1256025d9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.